©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Mar 28, 2023; 29(12): 1863-1874
Published online Mar 28, 2023. doi: 10.3748/wjg.v29.i12.1863
Published online Mar 28, 2023. doi: 10.3748/wjg.v29.i12.1863
Comprehensive review on endoscopic ultrasound-guided tissue acquisition techniques for solid pancreatic tumor
Sakue Masuda, Kazuya Koizumi, Kento Shionoya, Ryuhei Jinushi, Makomo Makazu, Takashi Nishino, Karen Kimura, Chihiro Sumida, Jun Kubota, Chikamasa Ichita, Akiko Sasaki, Masahiro Kobayashi, Makoto Kako, Department of Gastroenterology, Shonan Kamakura General Hospital, Kanagawa 247-8533, Japan
Uojima Haruki, Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Kanagawa 252-0375, Japan
Author contributions: Masuda S and Koizumi K were major contributors to writing the manuscript; Shionoya K, Jinushi R, Makazu M, Nishino T, and Kimura K designed the outline and coordinated the writing of the manuscript; Sumida C, Kubota J, Ichita C, Sasaki A, Kobayashi M, Kako M, and Haruki U provided input for writing the paper.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Corresponding author: Sakue Masuda, MD, Chief Doctor, Department of Gastroenterology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa 247-8533, Japan. sakue.masuda@tokushukai.jp
Received: December 27, 2022
Peer-review started: December 27, 2022
First decision: January 22, 2023
Revised: February 2, 2023
Accepted: March 15, 2023
Article in press: March 15, 2023
Published online: March 28, 2023
Processing time: 91 Days and 9.8 Hours
Peer-review started: December 27, 2022
First decision: January 22, 2023
Revised: February 2, 2023
Accepted: March 15, 2023
Article in press: March 15, 2023
Published online: March 28, 2023
Processing time: 91 Days and 9.8 Hours
Core Tip
Core Tip: Endoscopic ultrasound (EUS)-guided tissue acquisition (TA) began in 1992 as EUS-guided fine-needle aspiration (FNA). Recently, with the development of personalized medicine and precision treatment, the fine-needle biopsy (FNB) needle was developed. EUS-FNB is rapidly replacing EUS-FNA for pancreatic cancer. The EUS-TA strategy with three or more punctures, the stylet retraction method, the torque or fanning technique, and a 22-G or thicker FNB needle may be effective in patients with solid pancreatic tumors scheduled for treatment, including personalized medicine. It is also important clinicians are familiar with both procedures, as EUS-FNA is occasionally necessary when FNB is unsuccessful.